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Hypoxia leads to a massive release of neurotransmitter glutamate
resulting in overactivation of glutamate receptors during ischemic
stroke. These processes are usually accompanied by elevation of
hydrogen peroxide and nitric oxide generation which causes mito-
chondrial permeability transition and suppresses oxidative phosphor-
ylation. Meanwhile, it is possible to assume that a direct signaling
pathway linked hypoxia and mitochondria. Our aim was to study the
main biochemical mechanisms realized in mitochondria during
oxidation stress under hypoxia/reoxygenation conditions.
We used a model of mitochondria isolated from rat brain using
Percoll density centrifugation surviving under hypoxia. After 10 min
of incubation under hypoxic conditionsmitochondrial respiratory control
index (RCI) was reduced by 40%. This reduction of RCI was accompanied
by increased H2O2 generation. It was found that if the incubation of
mitochondria was carried out in the presence of glycine 5 mM and
MK-801 10 μM (an inhibitor of glutamate receptors), reduction of RCI
and increase of H2O2 generation was signiﬁcantly lower.
Whereas hypoxia causes elevation of glutamate concentration we
made a pioneering hypothesis that glutamate could activate signaling
processes in mitochondria by itself. Indeed a very low dose of
glutamate (5–50 μM) added to isolated mitochondria in the presence
of rotenone (inhibitor of complex I mitochondrial respiratory chain)
stimulates the generation of H2O2 up to 4 fold in a dose-dependent
manner. The process was signiﬁcantly reduced by MK-801 10 μM and
glycine 5 mM. These results suggest the possible existence of a
glutamate receptor in brain mitochondria.
Our ﬁndings suggest a novel mechanism by which brain
mitochondria could directly sense the signal of an elevated glutamate
level under hypoxia.
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The study was designed to investigate the beneﬁcial effect of
quercetin supplementation on rat brain mitochondrial bioenergetics,
oxidative stress and neurobehavioral impairments observed in a 3-
nitropropionic acid (3-NP) induced rodent model of Huntington's
disease (HD). A single oral dose of quercetin was supplemented to the
animals through gavage 1 h prior to 3-NP administration. However, a
sub-chronic dose of 3-NP was administered twice daily. On day 21,
after behavioral observation was recorded in all four groups, animals
were sacriﬁced and striatal mitochondrial fractions were obtained for
analyzing beneﬁcial effects of quercetin on several parameters such
as respiratory chain complexes including mitochondrial swelling,
antioxidative enzyme proﬁle, neurobehavioral deﬁcits and histopath-
ological changes. Quercetin supplemented animals showed a signif-
icant improvement of respiratory chain complexes accompanied by
decreased mitochondrial swelling, resulting in decreased generation
of mitochondrial oxidative stress in terms of lowered levels of lipid
peroxidation, improved functioning of superoxide dismutase, catalase
and thiol levels in comparison to 3-NP induced HD animals. Improved
neurobehavioral abilities following quercetin supplementation were
also observed on behavioral tasks (narrow beamwalk, actophotometer
and gait analysis) given to the animals. Also, histopathological features
in striatal tissue showed less or absent pyknotic nuclei and astrogliosis
in quercetin supplemented animals as compared to 3-NP administered
animals. Altogether, our results show that quercetin supplementation
to 3-NP induced HD animals ameliorated mitochondrial dysfunctions,
mitochondrial oxidative stress and neurobehavioral deﬁcits, showing
the capability of this ﬂavonoid in improving mitochondrial functions,
suggesting a putative role of quercetin in HD management.
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Lysosomal storage disorders are a group of rare inherited
metabolic disorders, of which, Gaucher disease (GD) is the most
common. GD is caused by mutations in the glucocerebrosidase (GBA)
gene. A loss of functional GBA in the lysosomes leads to accumulation
of glucocerebroside, resulting in non-functional organelles. This has
far reaching implications in the autophagy process, where lysosomes
fuse with autophagosomes to degrade unwanted or damaged cellular
material. Strong evidence has emerged linking lysosomal dysfunction
and Parkinson's disease (PD); individuals with a heterozygous
mutation in GBA have a ﬁve fold increased risk of developing PD
and those with a homozygous loss of GBA have up to a twenty fold
increased risk. Individuals with loss of GBA activity have the highest
genetic predisposition to developing PD.
Using amurinemodel of type II neuropathic GD, primary neurons and
astrocytes from gba−/− mice have reduced mitochondrial membrane
potential and hydrolyse ATP in order to maintain it. This reduction in
membrane potential coincides with mitochondrial fragmentation
in neurons and astrocytes due to increased OPA1 processing. This
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